By Robb M. Stewart Bausch + Lomb is offering $1.4 billion in debt and is looking to secure an incremental term loan facility to help finance the planned.
By Robb M. Stewart Bausch + Lomb shares jumped Friday after the eye-care company moved to buy a dry-eye drug from Novartis for up to $2.5 billion. In late.
By Robb M. Stewart Bausch + Lomb shares jumped Friday after the eye-care company moved to buy a dry-eye drug from Novartis for up to $2.5 billion. In late morning trading, the shares were.
Health-care companies rose sharply as traders chased momentum in one of the strongest-performing sectors in the first half of the year. Contact lens maker.
Ophthalmology Execs Investigate Tech Upending Eye Care - Orange County Business Journal ocbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ocbj.com Daily Mail and Mail on Sunday newspapers.